MX366768B - Tableta orodispersable de sildenafil y metodo para preparar la misma. - Google Patents

Tableta orodispersable de sildenafil y metodo para preparar la misma.

Info

Publication number
MX366768B
MX366768B MX2011013159A MX2011013159A MX366768B MX 366768 B MX366768 B MX 366768B MX 2011013159 A MX2011013159 A MX 2011013159A MX 2011013159 A MX2011013159 A MX 2011013159A MX 366768 B MX366768 B MX 366768B
Authority
MX
Mexico
Prior art keywords
orodispersible
preparation
sildenafil
tablet
sildenafil tablet
Prior art date
Application number
MX2011013159A
Other languages
English (en)
Other versions
MX2011013159A (es
Inventor
Hinojosa Raúl Arturo Moreno
Garcia Leonardo Martinez
Flores Oliver Daniel Walls
Original Assignee
Laboratorios Liomont S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48573651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX366768(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Liomont S A De C V filed Critical Laboratorios Liomont S A De C V
Priority to MX2011013159A priority Critical patent/MX366768B/es
Priority to PCT/IB2012/057043 priority patent/WO2013084191A1/es
Publication of MX2011013159A publication Critical patent/MX2011013159A/es
Priority to GT201400108A priority patent/GT201400108A/es
Priority to CO14122562A priority patent/CO7091173A2/es
Priority to CL2014001487A priority patent/CL2014001487A1/es
Publication of MX366768B publication Critical patent/MX366768B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Abstract

La presente invención se refiere a una tableta orodispersable que comprende el agente activo sildenafil, uno o más diluyentes; uno o más desintegrantes; uno o más aglutinantes, y opcionalmente, uno o más aditivos farmacéuticamente aceptables, y al procedimiento para preparar la misma.
MX2011013159A 2011-12-08 2011-12-08 Tableta orodispersable de sildenafil y metodo para preparar la misma. MX366768B (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
MX2011013159A MX366768B (es) 2011-12-08 2011-12-08 Tableta orodispersable de sildenafil y metodo para preparar la misma.
PCT/IB2012/057043 WO2013084191A1 (es) 2011-12-08 2012-12-06 Tableta orodispersable de sildenafil y método para preparar la misma
GT201400108A GT201400108A (es) 2011-12-08 2014-06-06 Tableta orodispersable de sildenafil y método para preparar la misma
CO14122562A CO7091173A2 (es) 2011-12-08 2014-06-06 Tableta orodispersable de sildenafil y metodo para preparar la misma
CL2014001487A CL2014001487A1 (es) 2011-12-08 2014-06-06 Tableta orodispersable que comprende al compuesto 5-[2-etoxi-5-(4-metil-1-piperazinilsulfonil)fenil]-1-metil-3-n-propil-1,6-dihidro-7h-pirazolo[4,3-d]pirimidin-7-ona (sildenafil), inhibidor de fosfodiesterasa tipo 5 (pde5), uno o mas diluyentes, disgregantes, aglutinantes y opcionalmente aditivos; y procedimiento para prepararla.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011013159A MX366768B (es) 2011-12-08 2011-12-08 Tableta orodispersable de sildenafil y metodo para preparar la misma.

Publications (2)

Publication Number Publication Date
MX2011013159A MX2011013159A (es) 2013-06-14
MX366768B true MX366768B (es) 2019-07-17

Family

ID=48573651

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011013159A MX366768B (es) 2011-12-08 2011-12-08 Tableta orodispersable de sildenafil y metodo para preparar la misma.

Country Status (5)

Country Link
CL (1) CL2014001487A1 (es)
CO (1) CO7091173A2 (es)
GT (1) GT201400108A (es)
MX (1) MX366768B (es)
WO (1) WO2013084191A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104546779A (zh) * 2013-10-14 2015-04-29 深圳海王药业有限公司 高药物荷载的枸橼酸西地那非片剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.
EP1120120A4 (en) * 1998-10-05 2009-04-29 Eisai R&D Man Co Ltd TABLETS DISSOLVING DIRECTLY IN MOUTH
WO2011030351A2 (en) * 2009-09-03 2011-03-17 Rubicon Research Private Limited Taste - masked pharmaceutical compositions

Also Published As

Publication number Publication date
GT201400108A (es) 2016-04-15
CL2014001487A1 (es) 2015-02-13
MX2011013159A (es) 2013-06-14
CO7091173A2 (es) 2014-10-21
WO2013084191A9 (es) 2013-08-15
WO2013084191A1 (es) 2013-06-13

Similar Documents

Publication Publication Date Title
MX2019002979A (es) Formulaciones de anticuerpos.
TW201144301A (en) Processes for preparing linezolid
MX364229B (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
MX2013008390A (es) Preparacion de estructuras de metal-triazolato.
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
MX2013012542A (es) Compuestos de amida y aplicacion farmaceutica para el mismo.
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12014501273A1 (en) Intranasal dexmedetomidine compositions and methods of use thereof
AU2012209332A8 (en) Methods and compositions for preparing noribogaine from voacangine
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
MX359288B (es) Forma iv del clorhidrato de ivabradina.
AU2013225816A8 (en) Compositions and methods for treating Type III Gaucher Disease
PH12016501841A1 (en) Immunosuppressant formulation
IN2013MU01985A (es)
IN2014DN10669A (es)
PH12014501367A1 (en) Processes for making magnolol and derivatives thereof
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
WO2012139074A3 (en) Migrastatins and uses thereof
MX366768B (es) Tableta orodispersable de sildenafil y metodo para preparar la misma.
WO2014013511A3 (en) Rufinamide solid dispersion
CA145238S (en) Cup for tea
IN2013MU01226A (es)
UA70710U (ru) Способ профилактики рецидивов аллергодерматозов у больных с вторичными иммунодефицитными состояниями

Legal Events

Date Code Title Description
FG Grant or registration